Position in SVRA
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$574,790
New position
Shares Held
105,273
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 184 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. SVRA ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
523,291 | $49,252,148 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
565,424 | $13,999,896 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,059 | $13,953,104 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
146,717 | $9,482,319 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
405,892 | $9,035,155 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,608 | $2,504,195 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,819 | $1,478,181 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,716 | $1,135,138 |
All Filings in SVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $574,790 | 105,273 | Shares | Sole | 2026-05-26 | |
| No filing history on record for this holder in this stock. | ||||||